Detalhe da pesquisa
1.
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever.
Clin Infect Dis
; 77(4): 565-573, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099356
2.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Clin Immunol
; 251: 109321, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019421
3.
Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018.
Front Virol
; 22022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461745